Iterum Therapeutics
ITRM
ITRM was delisted on the 31st of March, 2026.
24 hedge funds and large institutions have $2.38M invested in Iterum Therapeutics in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
73% more capital invested
Capital invested by funds: $1.38M → $2.38M (+$1M)
20% more funds holding
Funds holding: 20 → 24 (+4)
2.74% more ownership
Funds ownership: 3.23% → 5.97% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$476K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$449K |
| 3 |
Renaissance Technologies
New York
|
+$241K |
| 4 |
Jane Street
New York
|
+$96.9K |
| 5 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
+$62.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LF
Lee Financial
Dallas,
Texas
|
-$19.7K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$13.2K |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
-$2 |
ITRM Hedge Fund Activity: Q2 2025 in Review
24 institutional investors reported a position in Iterum Therapeutics (ITRM) for Q2 2025, worth a combined $2.38M — up 73% from $1.38M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ITRM positions and 2 closed out — a net gain of 4 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Squarepoint, opening a new position worth an estimated $476K. The largest seller was Lee Financial, exiting entirely with an estimated $19.7K sold.
- 24 institutional investors held Iterum Therapeutics (ITRM) as of Q2 2025, up from 20 in Q1 2025.
- Funds reported $2.38M of Iterum Therapeutics stock for Q2 2025, up 73% quarter-over-quarter.
- 6 funds opened new Iterum Therapeutics positions in Q2 2025 and 2 closed out, a net change of +4 holders.
- The largest Iterum Therapeutics buyer in Q2 2025 was Squarepoint, an estimated $476K added.
- The largest Iterum Therapeutics seller in Q2 2025 was Lee Financial, an estimated $19.7K sold.
Based on aggregated 13F filings for Q2 2025.